Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.99% | -44.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.99% | -44.75% | |||
| Cost of Revenue | -15.71% | -13.93% | |||
| Gross Profit | -11.51% | -53.79% | |||
| SG&A Expenses | 3.30% | -1.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.61% | -7.29% | |||
| Operating Income | -24.53% | -584.23% | |||
| Income Before Tax | -79.62% | -330.52% | |||
| Income Tax Expenses | -107.06% | 22.49% | |||
| Earnings from Continuing Operations | -58.38% | -442.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.38% | -442.97% | |||
| EBIT | -24.53% | -584.23% | |||
| EBITDA | -26.97% | -439.28% | |||
| EPS Basic | -58.12% | -442.60% | |||
| Normalized Basic EPS | -4.76% | -330.14% | |||
| EPS Diluted | -58.32% | -447.40% | |||
| Normalized Diluted EPS | -4.76% | -332.65% | |||
| Average Basic Shares Outstanding | 0.16% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.16% | -0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||